Self-administration of cocaine, cannabis and heroin in the human laboratory: Benefits and pitfalls

Addiction Biology

Volumn 14, Issue 1, 2009, Pages 9-21

  Haney, Margaret ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Addiction; Dependence; Marijuana; Opioid; Reinforcement; Validity

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CANNABIS; COCAINE; DIAMORPHINE; DRONABINOL; ECOPIPAM; LOFEXIDINE; METHADONE; MODAFINIL; NALTREXONE; OPIATE;

ABSTINENCE; CANNABIS ADDICTION; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG SELF ADMINISTRATION; DRUG SURVEILLANCE PROGRAM; DRUG TOLERANCE; DRUG URINE LEVEL; FOOD AND DRUG ADMINISTRATION; HELP SEEKING BEHAVIOR; HUMAN; IRRITABILITY; METHADONE TREATMENT; MOOD CHANGE; MORPHINE ADDICTION; MOTIVATION; OPIATE ADDICTION; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REPEATED DRUG DOSE; RESEARCH SUBJECT; REVIEW; SLEEP DEPRIVATION; SUBSTANCE ABUSE; VOLUNTEER; WITHDRAWAL SYNDROME;

CANNABINOIDS; COCAINE; COCAINE-RELATED DISORDERS; HEROIN; HEROIN DEPENDENCE; HUMANS; MARIJUANA ABUSE; MODELS, PSYCHOLOGICAL; SELF ADMINISTRATION; SOCIAL ENVIRONMENT; STREET DRUGS; TREATMENT OUTCOME;

EID: 57349123535     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2008.00121.x     Document Type: Review

References (106)

1. Altman JL, Meyer RE, Mirin SM, McNamee HB, McDougle M (1976) Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study. Int J Addict 11 : 485 499.
2. Arendt M, Rosenberg R, Foldager L, Sher L, Munk-Jørgensen P (2007) Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict 16 : 461 467.
3. Balster RL (1991) Drug abuse potential evaluation in animals. Br J Addict 86 : 1549 1558.
4. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV (2006) A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend 81 : 267 274.
5. Brady JV, Griffiths RR, Hienz RD, Ator NA, Lukas SE, Lamb RJ (1987) Assessing drugs for abuse liability and dependence potential in laboratory primates. In : Bozarth MA, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs, pp. 45 86. New York : Springer Verlag.
6. Budney AJ, Hughes JR, Moore BA, Vandrey R (2004) Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 161 : 1967 1977.
7. Budney AJ, Novy PL, Hughes JR (1999) Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 94 : 1311 1321.
8. Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B (2007) Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend 86 : 22 29.
9. Campbell J, Nickel EJ, Penick EC, Wallace D, Gabrielli WF, Rowe C, Liskow B, Powell BJ, Thomas HM (2003) Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. Am J Addict 12 : 122 136.
10. Carter BL, Tiffany ST (1999) Cue-reactivity and the future of addiction research. Addiction 94 : 349 351.
11. Chait LD, Burke KA (1994) Preference for high- versus low-potency marijuana. Pharmacol Biochem Behav 49 : 643 647.
12. Chait LD, Zacny JP (1992) Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans. Psychopharmacology (Berl) 107 : 255 262.
13. Collins E, Kleber HD (2004) Opioids: detoxification. In : Galanter M, Kleber HD, eds. Textbook of Substance Abuse Treatment, 3rd edn, pp. 265 290. Washington, DC : The American Psychiatric Publishing, Inc.
14. Collins SL, Levin FR, Foltin RW, Kleber HD, Evans SM (2006) Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend 82 : 158 167.
15. Collins ED, Vosburg SK, Hart CL, Haney M, Foltin RW (2003) Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans. Pharmacol Biochem Behav 76 : 401 407.
16. Collins ED, Ward AS, McDowell DM, Foltin RW, Fischman MW (1998) The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav Pharmacol 9 : 587 598.
17. Comer SD, Ashworth JB, Foltin RW, Johanson C.-E, Zacny JP, Walsh SL (2008) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96 : 1 15.
18. Comer SD, Collins ED, Fischman MW (1997) Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol 8 : 677 690.
19. Comer SD, Collins ED, Fischman MW (2001) Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans. Psychopharmacology 154 : 28 37.
20. Comer SD, Collins ED, Klever HD, Nuwayser ES, Kerrigan JH, Fischman MW (2002) Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology 159 : 351 360.
21. Comer SD, Collins ED, MacArthur RB, Fischman MW (1999) Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology 143 : 327 338.
22. Comer SD, Collins ED, Wilson ST, Donovan MR, Foltin RW, Fischman MW (1998) Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol 345 : 13 26.
23. Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ (2008) Relative abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abuser. Neuropsychopharmacology 33 : 1179 1191.
24. Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP (2006) Injectable, sustained-release naltrexone for the treatment of opioid dependence. Arch Gen Psychiatry 63 : 210 218.
25. Comer SD, Walker EA, Collins ED (2005) Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers. Psychopharmacology 181 : 664 675.
26. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 : 205 211.
27. Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O'Brien CP (2003) Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70 : 29 37.
28. Dole VP (1988) Implications of methadone maintenance for theories of narcotic addiction. JAMA 260 : 3025 3029.
29. Donny EC, Bigelow GE, Walsh SL (2003) Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. Drug Alcohol Depend 69 : 289 301.
30. Donny EC, Bigelow GE, Walsh SL (2004) Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming. Psychopharmacology 172 : 316 323.
31. Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL (2005) Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction 100 : 1496 1509.
32. Donny EC, Dierker LC (2007) The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend 89 : 93 96.
33. Donovan JL, DeVane CL, Malcolm RJ, Mojsiak J, Chiang CN, Elkashef A, Taylor RM (2005) Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet 44 : 753 765.
34. Dudish SA, Pentel PR, Hatsukami DK (1996) Smoked cocaine self-administration in females. Psychopharmacology (Berl) 123 : 79 87.
35. Dudish-Poulsen SA, Hatsukami DK (1997) Dissociation between subjective and behavioral responses after cocaine stimuli presentations. Drug Alcohol Depend 47 : 1 9.
36. Ehrman RN, Robbins SJ, Childress AR, O'Brien CP (1992) Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) 107 : 523 529.
37. Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) 168 : 31 41.
38. Epstein DH, Preston KL, Stewart J, Shaham Y (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 189 : 1 16.
39. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P (2003) Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 3 : CD002208.
40. Fischman MW, Foltin RW (1998) Cocaine self-administration research: implications for rational pharmacotherapy. In : Higgins ST, Katz JL, eds. Cocaine Abuse Research: Pharmacology, Behavior and Clinical Applications, pp. 181 207. San Diego : Academic Press.
41. Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253 : 760 770.
42. Foltin RW, Fischman MW (1992) Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther 261 : 841 849.
43. Foltin RW, Fischman MW (1994) Effects of buprenorphine on self-administration of cocaine by humans. Behav Pharmacol 5 : 79 89.
44. Foltin RW, Fischman MW (1997a) A laboratory model of cocaine withdrawal in humans: intravenous cocaine. Exp Clin Psychopharmacol 5 : 404 411.
45. Foltin RW, Fischman MW (1997b) Residual effects of repeated cocaine smoking in humans. Drug Alcohol Depend 47 : 117 124.
46. Foltin RW, Fischman MW, Perdroso JJ, Pearlson GD (1987) Marijuana and cocaine interaction in humans: cardiovascular consequences. Pharmacol Biochem Behav 28 : 459 464.
47. Foltin RW, Haney M (2000) Conditioned effects of environmental stimuli paired with smoked cocaine in humans. Psychopharmacol 24 : 24 29.
48. Gossop M, Griffiths P, Powis B, Strang J (1994) Cocaine: patterns of use, route of administration, and severity of dependence. Br J Psychiatry 164 : 660 664.
49. Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, Bailey R (2000) Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol 20 : 305 310.
50. Haney M (2005) The marijuana withdrawal syndrome: diagnosis and treatment. Curr Psychiatry Rep 7 : 360 366.
51. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999a) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143 : 102 110.
52. Haney M, Comer SD, Ward AS, Foltin RW, Fischman MW (1997) Factors influencing marijuana self-administration by humans. Behav Pharmacol 8 : 101 112.
53. Haney M, Foltin RW, Fischman MW (1998) Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 137 : 15 24.
54. Haney M, Hart CL, Foltin RW (2006) Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 31 : 1841 1821.
55. Haney M, Hart CL, Vosburg SK, Comer SD, Collins Reed S, Foltin RW (2008) Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology 197 : 157 168.
56. Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29 : 158 170.
57. Haney M, Spealman R (2008) Controversies in translational research: drug self-administration. Psychopharmacology, Epub Feb, DOI 10.1007/s00213-008-1079.
58. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999b) Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 4 : 395 404.
59. Haney M, Ward AS, Foltin RW, Fischman MW (2001a) Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 155 : 330 337.
60. Haney M, Ward AS, Gerra G, Foltin RW (2001b) Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans. Drug Alcohol Depend 64 : 63 73.
61. Hart C, Ward AS, Haney M, Comer SC, Foltin RW, Fischman MW (2002) Comparison of smoked marijuana and oral D9-tetrahydrocannabinol in humans. Psychopharmacology 154 : 407 415.
62. Hart CL, Haney M, Collins ED, Rubin E, Foltin RW (2007) Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend 86 : 274 277.
63. Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson E, Foltin RW (2006) Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology 31 : 1526 1536.
64. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2008) Human smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33 : 761 768.
65. Hart CL, Ward AS, Collins ED, Haney M, Foltin RW (2004) Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend 73 : 279 287.
66. Higgins ST, Bickel WK, Hughes JR (1994) Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 55 : 179 187.
67. Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology (Berl) 97 : 59 64.
68. Jasinski DR (2000) An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 14 : 53 60.
69. Jones BE, Prada JA (1975) Drug-seeking behavior during methadone maintenance. Psychopharmacologia 41 : 7 10.
70. 9-THC content? Exp Clin Psychopharmacol 5 : 74 82.
71. Kirchmayer U, Davoli M, Verster AD, Amato L, Ferri A, Perucci CA (2002) A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 97 : 1241 1249.
72. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE (2006) Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31 : 644 650.
73. Kouri EM, Pope HG Jr. 2000) Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol 8 : 483 492.
74. Levin FR, McDowell D, Evans SM, Brooks D, Akerele E, Donovan S, Nunes E (2004) Pharmacotherpay for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict 13 : 21 32.
75. Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV (1999) Pergolide mesylate for cocaine abuse: a controlled preliminary trail. Am J Addict 8 : 120 127.
76. Lile JA, Nader MA (2003) The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models. Current Neuropharmacology 1 : 21 46.
77. Malcolm R, Herron J, Sutherland SE, Brady KT (2001) Adverse outcomes in a controlled trial of pergolide for cocaine dependence. J Addict Dis 20 : 81 92.
78. Malcolm R, Swayngim K, Donovan JL, DeVane CL, Elkashef A, Chiang N, Khan R, Mojsiak J, Myrick DL, Hedden S, Cochran K, Woolson RF (2006) Modafinil and cocaine interactions. Am J Drug Alcohol Abuse 32 : 577 587.
79. McCance-Katz E, Kosten TA, Kosten TR (2001) Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development. Psychopharmacology 155 : 327 329.
80. Mello NK, Mendelson JH (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 207 : 657 659.
81. Mello NK, Mendelson JH, Kuehnle JC (1982) Buprenorphine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther 223 : 30 39.
82. Mello NK, Mendelson JH, Kuehnle JC, Sellers MS (1981) Operant analysis of human heroin self-administration and the effects of naltrexone. J Pharmacol Exp Ther 216 : 45 54.
83. Mendelson JH, Kuehnle JC, Greenberg I, Mello NK (1976) Operant acquisition of marijuana in man. J Pharmacol Exp Ther 198 : 42 53.
84. Mendelson JH, Mello NK (1984) Reinforcing properties of oral (9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use. Psychopharmacology 83 : 351 356.
85. Meyer RE, McNamee HB, Mirin SM, Altman JL (1976) Analysis and modification of opiate reinforcement. Int J Addict 11 : 467 484.
86. Myrick H, Malcolm R, Taylor B, LaRowe S (2004) Modafinil: preclinical, clinical, and post-marketing surveillance - a review of abuse liability issues. Ann Clin Psychiatry 16 : 101 109.
87. Negrete JC, Emil S (1992) Cue-evoked arousal in cocaine users: a study of variance and predictive value. Drug Alcohol Depend 30 : 187 192.
88. Petry NM (2001) Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology 154 : 243 250.
89. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R (2005) Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 62 : 1148 1156.
90. Rocha B, Bergman J, Comer SD, Haney M, Spealman RD (2008) Development of medications for heroin and cocaine addiction and regulatory aspects of abuse liability testing. In : McArthur RA, Borsini F, eds Animal and Translational Models of Behavioral Disorders, Vol. 3: Reward Deficit Disorders. New York : Elsevier In press).
91. Romach MK, Flue P, Kampman K, Kaplan HL, Somer GR, Poole S, Clarke L, Coffin V, Cornish J, O'Brien CP, Sellers EM (1999) Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166). Arch Gen Psychiatry 56 : 1101 1106.
92. Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF (2002a) Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol 13 : 105 115.
93. Rush CR, Kelly TH, Hays LR, Wooten AF (2002b) Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend 67 : 311 322.
94. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168 : 3 20.
95. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwattney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 148 : 33 40.
96. Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC, Ling W (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64 : 1440 1448.
97. Sinha R, Krishnan-Sarin S, Farren C, O'Malley S (1999) Naturalistic follow-up of drinking behavior following participation in an alcohol administration study. J Subst Abuse Treat 17 : 159 162.
98. Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64 : 327 336.
99. Stephens RS, Roffman RA, Curtin L (2000) Extended versus brief treatment for marijuana use. J Consult Clin Psychol 68 : 898 908.
100. Stephens RS, Roffman RA, Simpson EE (1993) Adult marijuana users seeking treatment. J Consult Clin Psychol 61 : 1100 1104.
101. Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR (2005) Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 182 : 186 193.
102. Strain EC, Bigelow GE, Liebson IA, Stitzer ML (1999) Moderate- vs high-dose methadone in opioid-dependent volunteers. Addiction 100 : 1496 1509.
103. Sullivan MA, Vosburg SK, Comer SD (2006) Depot naltrexone: antagonism of the reinforcing, subjective and physiological effects of heroin. Psychopharmacology 189 : 37 46.
104. Vocci FJ, Ling W (2005) Medications development. Pharmacol Ther 108 : 94 108.
105. Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE (2001) Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 299 : 147 158.
106. Ward AS, Comer SD, Haney M, Foltin RW, Fischman MW (1997) The effects of a monetary alternative on marijuana self-administration. Behav Pharmacol 8 : 275 286.